Treatment of Philadelphia Chromosome-Positive Early Chronic Phase Chronic Myelogenous Leukemia With Daily Doses of Interferon Alpha and Low-Dose Cytarabine PURPOSE: Blast expression of CD56 is ...
There is increasing interest in the development and application of cell-based therapy for cancer. Such approaches are dependent on the presence of functional effector cells. These include natural ...
Immunotherapy. 2011;3(9):1075-1086. MIP-1β release has also been observed for CD56 neg NK cells from patients with HCV infection. The above results suggest that the aberrant CD56 neg NK subset may ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results